References
- Canadian Institute for Health InformationNational Health Expenditure Trends, 1975 to 2013Ottawa, ONCIHI2013 Available from: https://secure.cihi.ca/free_products/NHEXTrendsReport_EN.pdfAccessed May 8, 2014
- DetskyASGuidelines for economic analysis of pharmaceutical products: a draft document for Ontario and CanadaPharmacoeconomics19933535436110146886
- RocchiAMenonDVermaSMillerEThe role of economic evidence in Canadian oncology reimbursement decision-making: to lambda and beyondValue Health200811477178318179658
- National Institute for Health and Clinical ExcellenceNICE announces measures on end of life medicines [press release]London, UKNICE2008115 Available from: http://www.nice.org.uk/media/6C4/6C/2008066MeasuresOnLifeMedicines.pdfAccessed June 17, 2014
- MorganSGMcMahonMMittonCCentralized drug review processes in Australia, Canada, New Zealand, and the United kingdomHealth Aff (Millwood)200625233734716522575
- McMahonMMorganSMittonCThe Common Drug Review: a NICE start for Canada?Health Policy200677333935116214257
- ClementFMHarrisALiJJYongKLeeKMMannsBJUsing effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and CanadaJAMA2009302131437144319809025
- Institut National d’Excellence en Santé et Services SociauxÉvaluation des médicaments [webpage on the Internet]Québec, QCGouvernement du Québec2014 Available from: http://www.inesss.qc.ca/index.php?id=42Accessed October 28, 2013 French
- Canadian Agency for Drugs and Technologies in HealthSearch CDR drug database [webpage on the Internet]Ottawa, ONCanadian Agency for Drugs and Technologies in Health2014 Available from: http://www.cadth.ca/en/products/cdr/searchAccessed October 28, 2013
- Ontario Public Drug ProgramDrugs Reviewed by the Interim Joint Oncology Drug Review (JODR) Process: March 2007 to PresentToronto, ONMinistry of Health and Long-Term Care2011 Available from: http://www.health.gov.on.ca/en/pro/programs/drugs/drug_submissions/pdf/drug_products_reviewed2.pdfAccessed October 28, 2013
- Ontario Public Drug ProgramsEO decisions and CED recommendations [webpage on the Internet]Toronto, ONMinistry of Health and Long-Term Care2014 [updated January 21, 2014]. Available from: http://www.health.gov.on.ca/en/pro/programs/drugs/ced_rec_table.aspxAccessed October 28, 2013
- Pan-Canadian Oncology Drug ReviewFind a review [webpage on the Internet]Toronto, ONPan-Canadian Oncology Drug Review2014 [updated June 17, 2014]. Available from: http://www.pcodr.ca/wcpc/portal/Home/FindaReview?_afrLoop=2226078236285000&lang=en&_afrWindowMode=0&_adf.ctrl-state=1bfprl5yfn_47Accessed October 28, 2013
- National Institute for Health and Care ExcellenceGuidance list [webpage on the Internet]London, UKNICE2014 Available from: http://www.nice.org.uk/guidance/published?type=TAAccessed October 28, 2013
- YongJHBecaJHochJSThe evaluation and use of economic evidence to inform cancer drug reimbursement decisions in CanadaPharmacoeconomics201331322923623322588
- RocchiAMillerEHopkinsRBGoereeRCommon Drug Review recommendations: an evidence base for expectations?Pharmacoeconomics201230322924622283689
- DevlinNDakinHRiceNParkinDO’NeillPNICE’s cost-effectiveness threshold revisited: new evidence on the influence of cost-effectiveness and other factors on NICE decisionsValue Health2010137A246
- Institut National d’Excellence en Santé et Services SociauxAccess to Cancer Drugs Deemed Promising: Situational Overview and Pilot Project Assessment. SummaryQuébec, QCINESSS2012 Available from: http://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/synthese_ONCO_mini_EN_21112012.pdfAccessed June 17, 2014
- Institut National d’Excellence en Santé et Services SociauxA view from Québec: updates from INESSPresentation at Market Access Summit, EyeforPharma. Proceedings of the 5th Annual Market Access CanadaOctober 28–29, 2013Toronto, ON
- MorganSGThomsonPADawJRFriesenMKInter-jurisdictional cooperation on pharmaceutical product listing agreements: views from Canadian provincesBMC Health Serv Res2013133423363626
- CollinsMLatimerNNICE’s end of life decision making scheme: impact on population healthBMJ2013346f136323518274
- HM GovernmentThe Coalition: Our Programme for GovernmentLondon, UKCabinet Office2010 Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/78977/coalition_programme_for_government.pdfAccessed October 28, 2013
- Department of HealthThe Cancer Drugs Fund: Guidance to Support Operation of the Cancer Drugs Fund in 2012–13London, UKCrown Copyright2012 Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216574/dh_133683.pdfAccessed May 8, 2014
- Department of HealthA New Value-Based Approach to the Pricing of Branded Medicines: A ConsultationLondon, UKCrown Copyright2010 Available from: http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_122793.pdfAccessed May 8, 2014
- National Institute for Health and Care ExcellencePublic Board Meeting Held on 20th November 2013 at 1.45 pm in Conference Rooms 1 and 2, Riddel Hall, Queens University Belfast, 185 Stranmillis Road, Belfast, BT9 5EE. Item 4: Value Based Assessment of Health TechnologiesLondon, UKNICE2014 Available from: http://www.nice.org.uk/media/B00/0E/January2014PublicBoardMeetingAgendaAndPapers.pdfAccessed May 8, 2014
- SpinnerDSBirtJWalterJWDo different clinical evidence bases lead to discordant health-technology assessment decisions? An in-depth case series across three jurisdictionsClinicoecon Outcomes Res20135698523403392